For Laboratory Research Use Only · Not for Human or Veterinary Use · 21+

Metabolic & Fat Loss Research

Tirzepatide

Tirzepatide

The dual-receptor heavyweight

$109.0025% OFF · code RESEARCH25
Third-Party TestedCOA Every VialUSA Shipped

What It Is

A synthetic 39-amino-acid peptide engineered to activate both the GIP and GLP-1 receptors simultaneously — a dual-agonist (“twincretin”) approach studied for combined incretin-pathway signaling on glucose handling and energy balance.

How It Works

Tirzepatide reference art
GLP-1R
Studied for appetite modulation at the hypothalamus, slowed gastric emptying, and glucose-dependent insulin release.
GIP-R
Studied for amplified insulin secretion and adipose-tissue lipolysis signaling.
Together
Investigated for dual-incretin synergy that single-pathway compounds do not model.

What the Research Shows

2022 · NEJM · SURMOUNT-1 (Jastreboff et al.)
Investigated body-weight endpoints over 72 weeks in a research setting.
2022 · NEJM · SURPASS-2
Investigated glycemic (HbA1c) endpoints versus a GLP-1 comparator.

Citations reference published research. For research purposes only; no therapeutic claims.

Research Focus

  • ✓Studied for dual-incretin synergy
  • ✓Investigated for metabolic-endpoint modeling
  • ✓Explored for glucose + energy-balance research

Blends Well With

Semaglutide
$100.00
Retatrutide
$124.00
NAD+
$54.00

Frequently Asked Questions

What is Tirzepatide?
A dual GIP/GLP-1 receptor agonist studied in metabolic research.
What receptors does it target?
GIPR and GLP-1R.
Is it FDA approved?
No — sold for research use only, not for human use.
Shop Tirzepatide · 25% off →

Code RESEARCH25 · applied at checkout

For research use only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease. Not evaluated by the FDA. 21+. US shipping only. Charge appears as GULFPORT LOGIS.
© 2026 Choice Peptide Labs